EXEL registry changes
Status changes, moved primary completion and completion dates, and results first posted on ClinicalTrials.gov, for trials linked to listed companies. Newest detection first.
Newest change detected Nov 19, 2026, 8:47 AM ET
| Detected | Trial | Change | Now | Before | Record updated |
|---|---|---|---|---|---|
| Nov 19, 2026, 8:47 AM ET | Status | Recruiting | Locked | Locked | |
| Nov 16, 2026, 8:47 AM ET | Completion date | Feb 29, 2028 (sponsor estimate) | Locked | Locked | |
| Nov 16, 2026, 8:47 AM ET | Primary completion date | Nov 30, 2027 (sponsor estimate) | Locked | Locked | |
| Nov 12, 2026, 8:11 AM ET | Status | Recruiting | Locked | Locked | |
| Nov 12, 2026, 8:11 AM ET | Completion date | Mar 21, 2033 (sponsor estimate) | Locked | Locked |
- Detected Nov 19, 2026, 8:47 AM ETStatusNCT07484139H&N NEO-COMBAT XL: Neoadjuvant XL-092 (Zanzalintinib) and Pembrolizumab (Keytruda) in Surgically Resectable, HPV Negative Oral Cavity...EXEL
- Now
- Recruiting
- Before
- Locked
- Detected Nov 16, 2026, 8:47 AM ETCompletion dateNCT07123103A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid TumorsEXEL
- Now
- Feb 29, 2028 (sponsor estimate)
- Before
- Locked
- Detected Nov 16, 2026, 8:47 AM ETPrimary completion dateNCT07123103A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid TumorsEXEL
- Now
- Nov 30, 2027 (sponsor estimate)
- Before
- Locked
- Detected Nov 12, 2026, 8:11 AM ETStatusNCT07845786Zanzalintinib and Pembrolizumab in First-Line Maintenance for Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)EXEL
- Now
- Recruiting
- Before
- Locked
- Detected Nov 12, 2026, 8:11 AM ETCompletion dateNCT07227402A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)MRKEXEL
- Now
- Mar 21, 2033 (sponsor estimate)
- Before
- Locked
The previous value and the sponsor's record update date are locked on 5 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerTracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.
What is on this list
Changes Signal8 recorded between two refreshes of a trial's ClinicalTrials.gov record: status, primary completion and completion dates, and results first posted. A change is shown when it was detected, which can be days after the sponsor updated the record. Nothing here describes what a trial showed.
New registrations, enrollment, eligibility and outcome-measure edits are not recorded. A status change is the registry's own word for where the trial stands, and "results posted" means results were posted to the registry, never what they show.
Free readers see the first 25 changes of any filter with the new value. The previous value, the sponsor's record update date and later pages are part of the plan. See the methodology.